Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Multiple Sclerosis

  Free Subscription


Articles published in Rev Neurol

Retrieve available abstracts of 22 articles:
HTML format



Single Articles


    April 2024
  1. ROJAS JI, Gracia F, Parciak T, Alonso R, et al
    [Core data set for real world data in multiple sclerosis: customization for latin america from a global task force recommendation].
    Rev Neurol. 2024;78:185-197.
    PubMed     Abstract available


    March 2024
  2. BARBOZA A, Sinay V, Alonso R, Carnero-Contentti E, et al
    [Comorbidities in multiple sclerosis and their influence on the choice of treatment].
    Rev Neurol. 2024;78:157-170.
    PubMed     Abstract available


    November 2023
  3. MILANOV I, Ivanova S, Tournev I, Chamova T, et al
    Real-world effectiveness of fingolimod in patients with multiple sclerosis in Bulgaria.
    Rev Neurol. 2023;77.
    PubMed     Abstract available


    August 2023
  4. NERI MJ, Mulero P, Tellez N
    [Nicolau syndrome due to self-injectable drugs in multiple sclerosis].
    Rev Neurol. 2023;77:75-78.
    PubMed     Abstract available


  5. TREJO-GABRIEL-GALAN JM, Cubo-Delgado E
    [Telephone assistance for neurological diseases: a systematic review].
    Rev Neurol. 2023;77:67-73.
    PubMed     Abstract available


    July 2023
  6. FERNANDEZ O, Montalban X, Aguera E, Aladro Y, et al
    [15th Post-ECTRIMS Meeting: a review of the latest developments presented at the 2022 ECTRIMS Congress (Part II)].
    Rev Neurol. 2023;77:47-60.
    PubMed     Abstract available


  7. FERNANDEZ O, Montalban X, Aguera E, Aladro Y, et al
    [15th Post-ECTRIMS Meeting: a review of the latest developments presented at the 2022 ECTRIMS Congress (Part I)].
    Rev Neurol. 2023;77:19-30.
    PubMed     Abstract available


    June 2023
  8. VIDAL-DE FRANCISCO D, Rosa-Garrido C, Ruiz-de Arcos M, Romero-Villarrubia A, et al
    [Family planning in men and women with multiple sclerosis. Analysis of the Andalusian Registry (2018-2022)].
    Rev Neurol. 2023;76:377-383.
    PubMed     Abstract available


    May 2023
  9. CANDELIERE-MERLICCO A, Villaverde-Gonzalez R, Hidalgo-Perez PV, Escobar-Arias FH, et al
    Dimethyl fumarate induced Wells syndrome. A case report.
    Rev Neurol. 2023;76:337-339.
    PubMed     Abstract available


    January 2023
  10. DE SA J, Ferreira J, Macedo AM
    [Actual adherence to dimethyl fumarate in patients with relapsing-remitting multiple sclerosis].
    Rev Neurol. 2023;76.
    PubMed     Abstract available


  11. SANCHEZ-VELASCO S, Midaglia L, Vidal-Jordana A, Castillo F, et al
    [Esclerosis multiple. Lactancia. Lactante. Planificacion familiar. Posparto. Tratamiento modificador de la enfermedad.].
    Rev Neurol. 2023;76:21-30.
    PubMed     Abstract available


    October 2022
  12. SALDANA-INDA I, Aparicio-Pelaz D, Rodriguez-Montolio J, Sebastian-Torres B, et al
    [Usefulness of the kappa index in the diagnosis of multiple sclerosis and validation of reference values in the Community of Aragon].
    Rev Neurol. 2022;75:181-187.
    PubMed     Abstract available


    May 2022
  13. LAFUENTE-GOMEZ G, Anaya-Fernandez Lomana F, Gomez-Roldos A, Garcia-Dominguez JM, et al
    [Periodic plasmapheresis as maintenance treatment in relapsing-remitting multiple sclerosis, a new therapeutic line? A case report].
    Rev Neurol. 2022;74:340-342.
    PubMed     Abstract available


    April 2022
  14. GARCIA-ESTEVEZ DA, Perez-Lorenzo G, Fernandez-Perez MJ, Cid-Rodriguez C, et al
    [Clinical and radiological effectiveness of natalizumab extended dosage interval in patients with relapsing multiple sclerosis].
    Rev Neurol. 2022;74:265-268.
    PubMed     Abstract available


    October 2021
  15. ZABAY-NEIRO MC, Nieves-Collado M, Carres-Gonzalez G, Curto-Estupina G, et al
    [Evaluation of the impact of lockdown on the health and lifestyle of users of the Fundacio Esclerosi Multiple's neurorehabilitation centres in Lleida and Reus].
    Rev Neurol. 2021;73:249-257.
    PubMed     Abstract available


    September 2021
  16. MIDAGLIA L, Sastre-Garriga J, Montalban X
    [Clinical monitoring of multiple sclerosis patients by means of digital technology, a field in the midst of a revolution].
    Rev Neurol. 2021;73:210-218.
    PubMed     Abstract available


    August 2021
  17. MECA-LALLANA V, Rodriguez-Antiguedad A, Llaneza MA, Meca-Lallana JE, et al
    [Plasma determination of neurofilaments as biomarkers in multiple sclerosis: conclusions of the EMotion Forum].
    Rev Neurol. 2021;73:101-110.
    PubMed     Abstract available


    June 2021
  18. FERNANDEZ O, Montalban X, Aladro Y, Alonso A, et al
    13th Post-ECTRIMS Meeting: review of the new developments presented at the 2020 ECTRIMS Congress (II).
    Rev Neurol. 2021;72:433-442.
    PubMed     Abstract available


  19. FERNANDEZ O, Montalban X, Aladro Y, Alonso A, et al
    13th Post-ECTRIMS Meeting: review of the new developments presented at the 2020 ECTRIMS Congress (I).
    Rev Neurol. 2021;72:397-406.
    PubMed     Abstract available


    April 2021
  20. COSTA FROSSARD-FRANCA L, Garcia-Dominguez JM, Moreno-Torres I, Fortun J, et al
    [Vaccination against SARS-CoV-2 in patients with multiple sclerosis].
    Rev Neurol. 2021;72:250-260.
    PubMed     Abstract available


    March 2021
  21. BENITO-VILLALVILLA D, Lopez de Uralde-Villanueva I, Rios-Leon M, Alvarez-Melcon AC, et al
    [Effectiveness of motor imagery in patients with multiple sclerosis: a systematic review].
    Rev Neurol. 2021;72:157-167.
    PubMed     Abstract available


    January 2021
  22. CRISTIANO E, Patrucco L, Ysrraelit MC, Alonso R, et al
    [Argentinean consensus guidelines on the identification and clinical care of secondary progressive multiple sclerosis].
    Rev Neurol. 2021;72:23-32.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.